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Abstract Vascular smooth muscle cells (VSMC) are
mature cells that maintain great plasticity. This distinctive
feature is the basis of the VSMC migration and prolifera-
tion involved in cardiovascular diseases. We have used a
proteomic approach to the molecular changes that promote
the switch of VSMC from having a quiescent to activated-
proliferating phenotype. In particular, we have focused on
modulations occurring during tyrosine-phosphorylation
following cell activation by serum or single growth factors,
such as insulin-like growth factor 1 or platelet-derived
growth factor. A comparison of two-dimensional polyacryl-
amide gel profiles from quiescent or activated-proliferating
VSMC has allowed us to recognize a number of differences
in protein expression. Several differentially expressed
proteins have been identified by mass spectrometry, and
their time-course changes during tyrosine-phosphorylation
have been documented from time zero till 48 h after
stimulation. We have documented a general decrease of the
tyrosine-phosphorylation level within the first few minutes
after stimulation followed by a recovery that is quick and
dramatic for some chaperones and redox enzymes but not
so significant for enzymes of glucose metabolism. With
regard to cytoskeleton components, no remarkable fluctua-
tions have been detected at the earliest time points, except
for those relative to α-actin, which displays an impressive
decrease. A comparison of the early stages of cell
stimulation after the administration of serum or single
growth factors has brought to light important differences in
the phosphorylation of chaperones, thereby suggesting their
crucial role in VSMC activation.
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Introduction
Vascular smooth muscle cells (VSMC) are mature cells that
maintain great plasticity and are capable of switching easily
from a contractile state to an activated synthetic phenotype
(Owens et al. 2004). Such plasticity is the basis of VSMC
migration and proliferation involved in the formation of
atheromas and/or hyperplasia of the neointima following
stent implantation. In the arterial wall, VSMC lie behind the
endothelium, which separates them from the blood flow.
When the vessel is injured, serum comes into contact with
VSMC, and growth factors, cytokines, and many other
soluble components probably interact with the plasma
membrane of the muscle cells, thereby activating complex
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signaling cascades. Among the elements involved in cell
activation, growth factors are the most extensively studied,
as several of them contribute to the formation of athero-
sclerotic and restenotic lesions (for reviews, see Ross 1993;
Cercek et al. 1991).
Our study focuses on the role of serum in SMC
activation compared with that of single growth factors such
as insulin-like growth factor 1 (IGF-1) and platelet-derived
growth factor (PDGF-BB). PDGF and IGF are important
regulators of VSMC death and proliferation (Kamide et al.
2000; Bayes-Genis et al. 2000; Hayashi et al. 2004). IGF-1
and PDGF-BB are known to act in synergy toward the
induction of cellular proliferation (Clemmons 1985),
probably through the up-regulation of IGF-receptor expres-
sion (Delafontaine et al. 1991; Rubini et al. 1994).
Antisense oligonucleotides, which inhibit the expression
of the IGF-receptor, reduce thrombin, angiotensin II, and
PDGF-induced mitogenesis in VSMC (Delafontaine et al.
2004), indicating that IGF-receptor activation is a rate-
limiting step in cell-cycle progression (Baserga and Rubin
1993).
PDGF-BB is known as the most potent chemoattractant
and mitogen for VSMC (Heldin and Westermack 1990;
Thyberg et al. 1990). During injury to blood vessels, PDGF
triggers phenotypic modulation, which is mediated by
changes in patterns of gene expression. Recently, a subset
of genes has been defined that are up- or down-regulated in
VSMC by PDGF (Kaplan-Albuquerque et al. 2005).
To date, studies have focused on the gene expression
profile involved in VSMC phenotypic modulation and have
produced some insight into the specific genes involved in
this process and their regulation. However, none have
succeeded in correlating either the genomic sequence or the
transcriptional profile with protein activation. Because the
importance of detaching functional proteins is becoming
increasingly clearer, we have tried a proteomic approach to
the study of VSMC activation. The most detailed map of
VSMC proteins that is currently available is that of
McGregor et al. (2001) who have studied the human
saphenous vein. An extensive protein profile of human
arterial VSMC has only recently been obtained (Dupont et
al. 2005).
In this study, we have focused our attention on early
stages of phenotypic modulation of VSMC following
stimulation by serum and growth factors, with an attempt
to identify some key elements of the complex activation
network at the initiation of phenotypic remodeling. In order
to gain further insights into the activation process, we have
examined time-course changes in tyrosine-phosphorylation
for 20 sequenced proteins.
In the early phases of the activation process, cells are
engaged in rapid responses that cannot rely on the synthesis
of new proteins but that probably depend upon previously
existing and post-translationally modified molecules. Con-
sequently, the molecules that are modulated in such a short
time could represent good prognostic markers and/or useful
pharmacological targets.
Materials and methods
Isolation of SMC and culture conditions
Coronaries were dissected from the myocardium of 3-
month-old domestic crossbred pigs (Sus scrofa domestica).
Medial VSMC were isolated by enzymatic digestion and
cultured according to the method described by Christen et
al. (1999). All experiments reported in this study were
performed with VSMC from between the second and the
sixth passages and, unless otherwise specified, from at least
three different explants.
The investigation conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication no. 85–23, revised
1996).
Cell cycle
Cells were fixed in 70% ethanol for 2 h at −20°C and
permeabilized with 0.25% Triton X-100 for 5 min at 4°C.
Cell suspensions were then centrifuged, and the pellets
were resuspended in 250 μl phosphate-buffered saline
(PBS) containing 100 mg/ml propidium iodide (Roche),
0.1 mg/ml RNAse (Roche), and 0.5% IGEPAL CA 630
(Sigma). Cells were passed through a flow cytometer
(FACScalibur, Becton Dickinson), and cell-cycle analysis
was carried out by using Cell Quest analysis software
(Becton Dickinson).
Chemotactic activity
Chemotaxis was assayed in Boyden chambers (Neuro
Probe). The chemoattractant used was 10% FBS in HG
DMEM, which was placed in the lower chamber. Bovine
serum albumin (0.1% BSA; fraction V, Sigma) was used as
a control under similar experimental conditions. Polyvinyl-
pyrrolidone-free 8-μm-pore polycarbonate filters were
coated with 5 mg/l porcine skin gelatin (Sigma) and placed
between the upper and lower chambers. Cells, suspended in
HG DMEM with 0.1% BSA, were placed in the upper
chambers at a density of 2×105 cells/chamber. After 5 h of
incubation at 37°C, filters were fixed in absolute ethanol for
30 s and stained with 2% toluidine blue (Sigma). Migrating
cells were counted on the lower side of the filter. Fifteen
fields for each filter were analyzed, and data were reported
as the average number of cells per field.
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Immunofluorescence analysis
Immunofluorescence analysis was carried out on cells
grown on coverslips. The cells were fixed for 30 min at
4°C with 2% paraformaldehyde in PBS and incubated
overnight with anti-SM-α-actin (1:200; Sigma, St Louis,
USA) or anti-smoothelin (1:4; R4A, Chemicon) monoclo-
nal antibodies. Incubation with the secondary antibody,
viz., Alexa Fluor 568 goat anti-mouse IgG (H+L) (1:3,000;
Molecular Probes), was performed at room temperature for
2 h. A few specimens were treated with rhodamine-labeled
phalloidin (Molecular Probes) for 20 min (1 unit in 200 μl
blocking solution per slide).
Two-dimensional gel electrophoresis, image acquisition,
and data analysis
Cell extracts Pellets from 106 VSMC were suspended in
250 μl conventional ice-cold two-dimensional (2-D) lysis
medium containing 8 M urea, 4% (w/v) CHAPS, 1% (w/v)
dithiothreitole (DTT), and 1 mM sodium orthovanadate.
Cells were gently vortexed and centrifuged at 13,000 rpm at
4°C for 45 min, and the supernatant was stored at −80°C
until used. The protein concentration was determined by
Bradford’s procedure (Bio-Rad Protein Assay, Bio-Rad).
Protein separation by isoelectrofocusing (1st dimension)
Separation by isoelectrofocusing (IEF) was carried out
according to the method originally described in Görg et al.
(1988) with pre-manufactured 18-cm-length strips display-
ing an immobilized non-linear pH gradient ranging from 3
to 10 (Amersham Biosciences, Uppsala, Sweden) run on a
Ettan IPGphor system (Amersham Biosciences). For
analytical runs, IPG strips were loaded and rehydrated at
16°C with 100 μg protein crude extracts in 350 μl lysis
buffer and 0.2% (v/v) carrier ampholyte (IPG buffer or
Pharmalyte 3–10) at 0 V for 1 h and at 30 V for an
additional 8 h. Focusing was performed at 16°C under the
following conditions: 200 V for 1 h, 300–3,500 V for 30
min, 3,500 V for 1 h, 3,500–8,000 V for 30 min, and
8,000 V until a total 80,000 Vh was attained. For
preparative runs, strips were loaded and rehydrated accord-
ing to the above conditions with 1,000 μg crude extracts in
the 350 μl lysis buffer.
Protein separation by denaturating gradient polyacryl-
amide gel electrophoresis (2nd dimension) Strips from the
above analytical or preparative 1st dimensional separation
were equilibrated for 12 min at room temperature in a
medium containing 6 M urea, 2% (w/v) SDS, 2% (w/v)
DTT, 30% (w/v) glycerol, and 0.05 M TRIS-HCl buffer pH
6.8 and then for an additional 5 min in a medium
containing 6 M urea, 2% (w/v) SDS, 2.5% (w/v) iodoacet-
amide, 30% glycerol, 0.05 M TRIS-HCl buffer, pH 6.8, and
a trace of bromophenol blue. The gel strips were loaded
onto the top of a 20 cm×20 cm×1.5 mm linear gradient
polyacrylamide gels ranging from 9% to 16% polyacryl-
amide. Runs were carried out at 9°C under constant voltage
at 120 V until the dye front had reached the bottom of gel.
Gel staining and image analysis For analytical runs, gels
were stained in ammoniacal silver nitrate according to the
method described in Hochstrasser et al. (1988). Gels in
preparative runs were stained in a highly sensitive colloidal
Coomassie G-250 blue dye according to the “Blue Silver”
protocol as described in Candiano et al. (2004). Stained
gels were scanned by using an Epson Expression 1680 Pro
Scanner (Seiko Epson, Japan), and digital images were
recorded and stored in appropriate formats. The analysis of
digital images was carried out with Image Master computer
software (GeneBio, Geneva, Switzerland). Values for the
isoelectric point (Ip) and mass (Da) of each spot were
calculated on the basis of separate co-migration runs
performed with human serum introduced as an internal
standard.
Immunodetection of Tyr-phosphoproteins Crude protein
extracts (120 μg) were separated by 2D gel electrophoresis
(2D-PAGE) and transferred onto nitrocellulose membranes
(Hybond-C, Amersham Life Science). Membranes were
checked for protein resolution with Ponceau red staining
and incubated overnight at 4°C with a mouse anti-
phosphotyrosine monoclonal antibody (IgG2b; Santa Cruz
Biotechnology) diluted 1:1,000 in 3% BSA, 0.1% Tween-
20 in PBS and then with the secondary antibody, viz., a
sheep anti-mouse IgG (Santa Cruz Biotechnology), diluted
1:3,000, for 1 h at room temperature. Chemiluminescence
was detected by using an ECLTM Detection Kit (Amer-
sham Biosciences).
Protein identification by mass spectrometry
Electrophoretic spots, visualized by colloidal Coomassie G-
250 staining, were excised manually, destained according to
the method described in Shevchenko et al. (1996), and
dehydrated. Successively, a trypsin solution was added, and
in-gel protein digestion was performed by overnight
incubation at 37°C. Digested peptides (0.75 μl/spot) were
mixed with 0.75 μl matrix solution, viz., a saturated
solution of cyclohexane carboxylic acid in 50% (v/v)
acetonitrile and 0.1% (v/v) trifluoroacetic acid, spotted
onto a MALDI plate and then allowed to dry. Peptide mass
fingerprintings were acquired by using a OmniFLEX
MALDI-TOF mass spectrometer (Bruker Daltonics Corpo-
ration, Billerica, Mass., USA). Peptide mass fingerprinting
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searches were carried out by using software available
online: ProFound, (http://www.129.85.19.192/profound_
bin/WebProFound.exe); PeptIdent, (http://www.expasy.
org); MASCOT (Matrix Science, London, UK; http://
www.matrixscience.com).
Results
VSMC, isolated from porcine coronaries and grown under
standard conditions in complete medium, displayed a
synthetic phenotype endowed with migrating properties
and proliferating activities. When serum was completely
withdrawn from culture medium (minus fetal bovine serum,
−FBS), cells rapidly switched to a quiescent-contractile
phenotype. Under these conditions, VSMC stopped prolif-
erating (Fig. 1a), blocking their cell cycle at the G1/G0
stage (Fig. 1b) without becoming apoptotic (data not
shown), and lost all chemotactic activity (Fig. 1c). They
acquired an elongated spindle-shaped morphology and
expressed cytoskeleton proteins specific for the contractile
phenotype, such as α-actin and smoothelin (Fig. 1d). The
addition of 10% FBS (+FBS) to medium switched cultures
back to a proliferating (Fig. 1a,b) and migrating (Fig. 1c)
type, supporting a round-shaped flat morphology, a de-
crease in α-actin expression, and a more consistent
reduction in smoothelin (Fig. 1d).
For further insights into such phenotypic changes, 2D-
PAGE was employed. VSMC were cultured for 2 days in the
absence of serum to induce the quiescent-contractile pheno-
type. Cultures were then split into two fractions: the first was
immediately collected, whereas the second was left for 2
additional days in complete medium to produce the activated
cells. Both recovered samples were processed for 2D-PAGE
analysis. Master gels (mean of four replicas) from quiescent-
contractile and activated VSMC (shown in Fig. 2a,b,
respectively) were analyzed to identify the spots differen-
tially expressed. Of the spots, 105 were up-regulated, and
154 were down-regulated in activated cells compared with
those observed in the quiescent-contractile state.
Some of the differentially expressed spots were localized
in a Coomassie-blue-stained preparative gel. These spots
were excised, digested in-gel by trypsin, and sequenced by
mass spectrometry. Sequenced proteins were subdivided
into three principal categories: (1) enzymes involved in
redox regulation and chaperones, viz., peroxiredoxin 3,
peroxiredoxin 4, protein disulfide isomerase (PDI), retic-
ulocalbin, Hsp60 and Hsp27; (2) cytoskeleton elements,
viz., tropomyosin α4 and α1 chain tropomyosin, α- and γ-
actins, vimentin, cytokeratin 10; (3) glucose metabolism
enzymes, viz., α-enolase, ATP synthase, pyruvate kinase,
and pyruvate dehydrogenase. Four other proteins, viz.,
hnRNP H, phohibitin, casein precursor and α−(B)crystal-
lin, were also identified but could not be restricted into a
specific class, even though they are all known to have
Fig. 1 a Cell proliferation. VSMC were maintained for 3 days in
serum free medium (-FBS) in order to consolidate the quiescent
phenotype. After this time (arrow), a complete medium, supple-
mented with a 10% fetal bovine serum, was added (+FBS), and the
cells were cultured for 2 additional days. Cells were counted every
day. Each point represents the mean±SD of three independent
experiments. b Cell cycle. The same samples as those in a (−FBS,
+FBS) were subjected to flow cytometric analysis. The M1, M2,
and M3 gates correspond to the G0/G1, S, and G2/M phases of cell
cycle, respectively. The mean±SD of three independent experi-
ments is reported. c Chemotactic activity. VSMC were allowed to
migrate through gelatin-coated filters in response to 10% FBS (S.)
or 0.1% BSA (BSA) as chemoattractors. Data were compared by
using the unpaired t-test. **P<0.01. Each bar shows the mean
±SD of three independent experiments. d Cytoskeleton proteins.
VSMC were analyzed by immunofluorescence microscopy in the
absence of serum (−FBS) or in serum-supplemented medium for
2 days (+FBS). Exposure to rhodamine-labeled phalloidin demon-
strated the presence of actin filaments. Smooth muscle markers
were revealed by immunolabeling for α-actin and smoothelin. The
corresponding phase-contrast images are shown bottom. Results
are representative of three independent experiments. Bar 40 μm

Fig. 2 Two-dimensional poly-
acrylamide gel electrophoresis
(2D-PAGE). Master gels as the
mean of four independently run
replicates of protein extracts
from quiescent-contractile (a)
and serum-activated (b) VSMC.
Proteins were separated by IEF
in 18-cm-long IPG strips con-
taining a non-linear pH 3–10
gradient followed by SDS-
PAGE in vertical 9%–16% gra-
dient gels. Proteins were
detected by silver staining
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important regulatory roles in activated cells and for cell-
cycle control (Table 1).
A comparison of the protein profile of VSMC at the
onset (quiescent-contractile) and at the terminal stage of the
process (activated) reflected a global view of two extreme
conditions but did not provide information about the
temporal kinetics of the event. Moreover, because the
stimulation of growth factor concerned the activation of
signal transduction networks characterized by several
tyrosine-kinase functions, we wanted to investigate the
way that the tyrosine-phosphorylation changed over time in
response to FBS administration. With this aim, we analyzed
the overall tyrosine-phosphorylation profile of quiescent
VSMC (0 time) and of VSMC after 10, 30, and 60 min and
2 days of serum stimulation. The 2D gels were blotted onto
nitrocellulose membranes, and phosphorylated spots were
detected with an anti-phosphotyrosine-specific monoclonal
antibody. Figure 3, which shows the time course of
tyrosine-phosphorylation changes, reveals a net decrease
of the phosphorylation level within the first 10 min,
followed by a slow recovery, with a value close to the
starting value after 48 h.
Tyrosine phosphorylation was followed over time for 20
antibody-sensitive spots corresponding to the sequenced
proteins (Fig. 4). The phosphorylation of glucose metabo-
lism enzymes greatly decreased at 10 min and remained
low for all proteins, except for ATP synthase (Fig. 4a).
Chaperones displayed a similar behavior in the first few
minutes after stimulus, but PDI and Hsp60 showed a
dramatic increase of phosphorylation after 10 and 30 min,
respectively, quickly reaching much higher values than
those observed initially (Fig. 4b). With regard to cytoskel-
eton proteins, α-actin and cytokeratin 10 displayed a
pattern similar to that of the glucose metabolism enzymes,
whereas none of the others varied significantly, at least
Table 1 Proteins identified by
mass spectrometry. Three dif-
ferent classes of proteins were
sequenced by mass spectrome-
try (Chaperones and redox
enzymes, Cytoskeleton compo-
nents, and Glucose metabolism
enzymes). Four proteins could
not be grouped into a homo-
geneous class (Others). Each
protein was identified accord-
ing to the Mascott database
(Score −10*Log [P], where P
is the probability that the ob-
served match is a random
event). Protein scores greater
than 80 are significant (P<
0.05)
Protein name ID Score
Chaperones and redox enzymes
Hsp60 (60-kDa heat-shock protein, mitochondrial precursor) P63038 230
PDIA3 (protein disulfide isomerase A3 precursor) P30101 331
Reticulocalbin 1 precursor Q15293 151
PRDX4 (peroxiredoxin 4) O08807 259
PRDX3 (thioredoxin-dependent peroxide reductase, mitochondrial precursor) P35705 94
Hsp27 (heat-shock protein beta-1, 27 kDa) P04792 82
Cytoskeleton elements
Vimentin P02544 186
Actin alpha P68032 215
Gamma-actin (actin, cytoplasmic 2) P63259 117
Tropomyosin4 (tropomyosin alpha 4 chain) P02561 156
Alpha-tropomyosin (tropomyosin 1 alpha chain) P58772 210
Cytokeratin 10 (keratin, type I cytoskeletal 10) P13645 113
Glucose metabolism enzymes
Pyruvate kinase M1/M2 P14618 140
Pyruvate dehydrogenase E1 component beta subunit, mitochondrial P11177 94
Alpha enolase Q9XSJ4 73
ATP synthase D chain, mitochondrial P13620 80
Others
Alpha(B)-crystallin (alpha crystallin B chain) P41316 104
hnRNP H (heterogeneous nuclear ribonucleoprotein H) O35737 79
Alpha-S1 casein precursor P02662 337
Prohibitin P35232 504
Fig. 3 Time-course experiments. Quiescent VSMC or cells stimulated
for 10, 30, or 60 min or 48 h were subjected to 2D-PAGE, the proteins
were blotted on nitrocellulose membranes, and the phosphorylated
spots were identified by an anti-phosphotyrosine monoclonal anti-
body. The curve shows the phosphorylation course over time,
expressed as the percentage of antibody-sensitive spots relative to
time zero
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during the first 30 min of stimulation (Fig. 4c). The
remaining proteins displayed non-homogeneous modula-
tion (Fig. 4d).
The time-course data offer a global view of the
activation profile concerning the sequenced proteins but
do not provide information relating the role of the various
factors present in the serum. Moreover, as is apparent from
the data presented so far, the most important changes take
place during the first 10 min after stimulation, with a
general trend subsequently to return to the initial values of
phosphorylation within 48 h from the beginning of the
process. For all these reasons, we compared the phosphor-
ylation profiles of VSMC stimulated for 10 min with serum
or a single growth factor, IGF-1 or PDGF-BB. Remarkable
differences were observed (Fig. 5a–d, Table 2). Changes in
the phosphorylation patterns were greater after PDGF-BB
than after IGF-1 or serum stimulation. Moreover, PDGF-
BB seemed to have a principal role in increasing tyrosine-
Fig. 4 Tyrosine phosphoryla-
tion relative to 20 sequenced
proteins. Sequenced proteins
were grouped into four classes:
glucose metabolism enzymes
(a), chaperones (b), cytoskele-
ton elements (c), and proteins
that were not classifiable into a
homogeneous category (d). The
level of phosphorylation is rep-
resented as volume percentage
(ΔV%) of the stained spots.
Volume percentage in d is rep-
resented by two separate scales
because of the elevated levels of
prohibitin
Fig. 5 Tyrosine phospho-
proteomes obtained from
2D-PAGE blotted onto nitrocel-
lulose membrane and probed
with a specific phosphotyrosine
monoclonal antibody. Phos-
phorylation profiles of quies-
cent-contractile VSMC (a) and
after 10 min of stimulation with
IGF-1 (b), PDGF-BB (c), or
FBS (d)
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phosphorylation (85% of modified spots), whereas IGF-1
and serum treatments were characterized by significant de-
phosphorylation (62% and 60% of modified spots in IGF-1
and FBS, respectively).
Histograms in Fig. 6 reveal the differences in phosphor-
ylation intensity attributable to FBS, IGF-I, or PDGF-BB
stimulation for 10 minutes. Tyrosine-phosphorylation
changes displayed similar responses for the glucose
metabolism enzymes, except for ATP synthase whose
phosphorylation did not change after single growth factor
stimulation (Fig. 6a). As far as the cytoskeleton compo-
nents are concerned, different behavior after serum or single
growth factor administration was observed (Fig. 6b).
Finally, chaperones displayed even more remarkable dif-
ferent responses to serum with respect to single growth
factors. Most of them, although reducing their phosphory-
lation level after 10 min of serum treatment, did not change
Table 2 Differentially phosphorylated spots after a 10-min stimula-
tion of quiescent-contractile VSMC with a single growth factor or
with serum
IGF PDGF FBS
Up-regulated spots 6 29 10
Down-regulated spots 10 5 15
Fig. 6 Comparative analysis of
proteins differentially phosphor-
ylated after 10 min by IGF-1,
PDGF-BB, or FBS stimulation.
The histograms report the tyro-
sine phosphorylation values
expressed as spot volume per-
centage (white bars phosphory-
lation level of quiescent VSMC
at time 0 in reference to which
all other values are normalized).
Proteins are separated into three
homogeneous classes: glucose
metabolism enzymes (a), cyto-
skeleton components (b), and
chaperones (c)
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or increase their phosphorylation level after single growth
factor activation (Fig. 6c).
Discussion
The switching of the VSMC phenotye has a great general
relevance for human health, as it is associated with several
vascular diseases. The distinction between synthetic and
contractile phenotypes proposed by Chamley-Campbell et
al. (1979) has been employed for decades and has been
useful in planning experiments and inspiring new studies.
However, we now realize that such a distinction represents
an oversimplification incapable of capturing the complex
and dynamic aspects of VSMC phenotype modulation
(Owens et al. 2004). Here, we approach this old topic with
a novel strategy by investigating, at the protein level, the
early changes that prime the signaling cascades leading to
the acquisition of a new phenotype.
With this aim, we have analyzed contractile-quiescent
and 48-h serum-activated VSMC by 2D-PAGE and have
identified some of the differentially expressed proteins. In
order to improve our understanding of the cellular pathways
involved in the activation process, we have explored the
phosphorylation pattern in VSMC during the activation
process and have recorded over time the tyrosine-phos-
phorylation changes for 20 sequenced proteins (from time 0
to 48 h).
Briefly, we have documented an initial general decrease
of the tyrosine-phosphorylation level within the first few
minutes after stimulation, with a subsequent recovery after
48 h to levels close to those at the start. Thus, in the early
stages of the activation course, important and significant
events occur favoring the activity of tyrosine phosphatases.
This is in accordance with a recent study, suggesting the
pivotal importance of phosphatases, such as SHP-2, in
directing VSMC toward a specific phenotype (Hayashi et
al. 2004). Although descriptive, the data regarding phos-
phorylation/de-phosphorylation are of interest as they offer
a global view of the early response, suggesting a possible
role of phosphatases in priming the activation process. This
is a novel aspect that deserves to be investigated more
extensively.
The phosphorylation kinetics observed during the time-
course analysis provide evidence for a homogeneous trend
among the different classes of proteins, although the
kinetics are specific for each protein. The most significant
results concern the chaperones, particularly Hsp60 and PDI
whose phosphorylation rate rapidly increases, reaching
impressive values much higher than those seen initially. For
the glucose metabolism enzymes (with the exception of
ATP synthase), there is a slow, yet partial, recovery toward
their initial values. As far as cytoskeleton proteins are
concerned, changes in tyrosine phosphorylation do not
appear to be remarkable, especially at the earliest time
points. An important exception is α-actin whose phosphor-
ylation level decreases to 0. This is not surprising as this
protein is one of the principal markers of the contractile
VSMC (Roy et al. 2001); its expression drops considerably
during the activation process as confirmed by our
fluorescence microscopy observations. At present, we
cannot make any conclusion regarding the degree to
which the decrease in phosphorylation signal is attribut-
able to actual de-phosphorylation or to a reduction in
protein concentration.
Because 10 min appears to be critical for the triggering
the complexity of the activation process following serum
administration, we have focused on this time point in order
to understand the role of single growth factors. To this
purpose, VSMC were treated for 10 min with IGF-1 or
PDGF-BB, the phosphorylation profiles were analyzed, and
the results compared with those obtained following serum
treatment. Of note, chaperones and redox-related enzymes
show the most significant differences depending on the
treatment. In particular, serum does not seem to be so
effective as the single factors for the induction of tyrosine-
phosphorylation. For example, Hsp60 and calumenin are
phosphorylated following PDGF-BB stimulation, but not
after IGF-1 or serum stimulation, whereas PDI is up-
phosphorylated after both IGF-1 and PDGF-BB, but serum
causes its de-phosphorylation. As far as Hsp27 is
concerned, both single growth factors induced a decrease
in phosphorylation, but to a smaller extent than serum.
From these data, we can conclude that each serum
component, depending on its concentration, might control
cellular metabolic pathways differently. In other words, as
the observed differences in the effects demonstrate, activa-
tion is a highly complex process in which each factor has a
distinctive and particular role.
Hsp60 has been well demonstrated as being involved in
cardiovascular diseases (Snoeckx et al. 2001; Pockley
2002). Barazi et al. (2002) have suggested a role for
surface-expressed Hsp60 in mediating the activation of
α3β1 integrin by modulating its conformation. Our data,
which provide evidence for a post-translational modifica-
tion of Hsp60 as a result of growth factor stimulation,
support the findings of Barazi et al. (2002) and suggest a
possible role for Hsp60 in VSMC migration.
Moreover, the data concerning PDI presented herein are
in agreement with those of Patton et al. (1995) who have
reported the up-regulation of PDI following hyperplastic
stimuli, such PDGF and 10% serum. PDI is commonly
located in the endoplasmic reticulum, but, like Hsp60, it is
also secreted at low levels from a variety of cell types and
has been found on the surface of cells (for a review, see
Wilkinson and Gilbert 2004). Interestingly, PDI is present
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on the surface of rat aortic VSMC in an active reduced
conformation and, in this location, might catalyze disulfide
interchange in thrombospondin 1 (TSP 1). In this way, PDI
might regulate the interaction between TSP 1 and PDGF,
playing a role in PDGF targeting to its receptors on VSMC
(Hogg et al. 1997).
Hsp27 is reported to have an actin-capping activity that
seems to be required for actin polymerization and efficient
motility induction, since limiting the length of the growing
branches would contribute to generating efficient propul-
sive forces (Pichon et al. 2004).
Briefly, our results support the concept that chaperones
in general, and stress-related proteins in particular, have
crucial roles in the first stages of activation process and are
presumably connected with cytoskeleton remodeling and
cell migration.
In conclusion, the most remarkable feature that
occurs during the early stages of VSMC activation,
irrespective of growth factor stimulation, is the recruit-
ment of chaperones, i.e., molecules devoted to the
maquillage and recycling of previously made proteins,
some of them being calcium-regulated and the majority
operating on cytoskeleton elements and being related to
cell motility. Our study raises a series of issues
concerning modulators of cell remodeling and also
provides interesting clues regarding the various mole-
cules involved in the early events of cell activation. In
our opinion, each single factor that we have identified is
worth being investigated more extensively; indeed, we
intend to utilize gene knock-down technology to
improve the characterization of the function of the
factors identified during the process of activation. Our
goal is the discovery of switches triggering the early
events of VSMC remodeling in order to design new
therapeutic strategies for the prevention and treatment of
cardiovascular diseases.
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